Dr. Salit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-667-1317Fax+1 410-328-0267
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2007 - 2011
University of MarylandResidency, Internal Medicine, 2004 - 2007
Loyola University Chicago Stritch School of MedicineClass of 2004
Certifications & Licensure
WA State Medical License 2012 - 2025
MD State Medical License 2007 - 2013- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Start of enrollment: 2009 Aug 25
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Start of enrollment: 2010 May 19
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsImpact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemiaJanghee Woo, Dae Ro Choi, Barry E. Storer, Cecilia Yeung, Anna B. Halpern
Haematologica. 2020-03-01 - 22 citationsA prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W. Beelen, Rachel B. Salit, Friedrich Stölzel
Blood Advances. 2021-03-23 - 5 citationsThe role of JAK inhibitors in hematopoietic cell transplantation.Rachel B Salit
Bone Marrow Transplantation. 2022-06-01
Journal Articles
- Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell TransplantationMary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica
Abstracts/Posters
- Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative SyndromesRachel B. Salit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisRachel B. Salit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplan...Rachel B. Salit, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
